New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2014
05:51 EDTLIFE, DGXLife Technologies signs multi-year license, supply agreement Quest Diagnostics
Life Technologies (LIFE) has completed a multi-year license and supply agreement with Quest Diagnostics (DGX), the world's leading provider of diagnostic information services, that gives Quest rights to develop molecular tests on the Ion Torrent next-generation sequencing platform. Under the agreement, Quest may use the platform and related consumables to independently develop new tests for numerous areas of their business.
News For LIFE;DGX From The Last 14 Days
Check below for free stories on LIFE;DGX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 8, 2014
16:06 EDTDGXQuest Diagnostics: More people testing positive for chikungunya virus in U.S.
Subscribe for More Information
September 3, 2014
10:00 EDTDGXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:17 EDTDGXQuest Diagnostics upgraded to Conviction Buy from Buy at Goldman
Goldman upgraded Quest Diagnostics to Conviction Buy from Buy based on expectations for improving industry volumes, cost cutting focus, margin expansion potential, and capital allocation. Price target raised to $78 from $66.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use